Alpha1-antitrypsin protects the immature mouse brain following hypoxic-ischemic injury

Introduction: Preterm brain injury often leads to lifelong disabilities affecting both cognitive and motor functions, and effective therapies are limited. Alpha1-antitrypsin (AAT), an endogenous inhibitor of serine proteinases with anti-inflammatory, anti-apoptotic, and cytoprotective properties, mi...

Full description

Bibliographic Details
Main Authors: Shan Zhang, Wendong Li, Yiran Xu, Tao Li, Joakim Ek, Xiaoli Zhang, Yafeng Wang, Juan Song, Changlian Zhu, Xiaoyang Wang
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-03-01
Series:Frontiers in Cellular Neuroscience
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fncel.2023.1137497/full
_version_ 1811159574932094976
author Shan Zhang
Shan Zhang
Wendong Li
Yiran Xu
Tao Li
Tao Li
Joakim Ek
Xiaoli Zhang
Yafeng Wang
Yafeng Wang
Juan Song
Changlian Zhu
Changlian Zhu
Changlian Zhu
Xiaoyang Wang
Xiaoyang Wang
Xiaoyang Wang
author_facet Shan Zhang
Shan Zhang
Wendong Li
Yiran Xu
Tao Li
Tao Li
Joakim Ek
Xiaoli Zhang
Yafeng Wang
Yafeng Wang
Juan Song
Changlian Zhu
Changlian Zhu
Changlian Zhu
Xiaoyang Wang
Xiaoyang Wang
Xiaoyang Wang
author_sort Shan Zhang
collection DOAJ
description Introduction: Preterm brain injury often leads to lifelong disabilities affecting both cognitive and motor functions, and effective therapies are limited. Alpha1-antitrypsin (AAT), an endogenous inhibitor of serine proteinases with anti-inflammatory, anti-apoptotic, and cytoprotective properties, might be beneficial in treating preterm brain injury. The aim of this study was to investigate whether AAT has neuroprotective effects in a mouse preterm brain injury model.Methods: Preterm brain injury was induced on postnatal day 5, and mouse pups’ right common carotid arteries were cut between two ligations followed by hypoxia induction. Brain injury was evaluated through immunohistochemistry staining and magnetic resonance imaging. Fluoro-Jade B and immunohistochemistry staining were performed to investigate the neuronal cell death and blood-brain barrier (BBB) permeability. The motor function and anxiety-like behaviors were revealed by CatWalk gait analysis and the open field test.Results: After hypoxia-ischemia (HI) insult, brain injury was alleviated by AAT treatment, and this was accompanied by reduced BBB permeability, reduced neuronal cell death and caspase-3 activation, and inhibition of microglia activation. In addition, AAT administration significantly improved HI-induced motor function deficiencies in mice. The neuroprotective effect of AAT was more pronounced in male mice.Conclusion: AAT treatment is neuroprotective against preterm brain injury in neonatal mice, and the effect is more pronounced in males.
first_indexed 2024-04-10T05:44:37Z
format Article
id doaj.art-c19ed1850b9b486bbaed4e22f565a25f
institution Directory Open Access Journal
issn 1662-5102
language English
last_indexed 2024-04-10T05:44:37Z
publishDate 2023-03-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Cellular Neuroscience
spelling doaj.art-c19ed1850b9b486bbaed4e22f565a25f2023-03-06T04:56:07ZengFrontiers Media S.A.Frontiers in Cellular Neuroscience1662-51022023-03-011710.3389/fncel.2023.11374971137497Alpha1-antitrypsin protects the immature mouse brain following hypoxic-ischemic injuryShan Zhang0Shan Zhang1Wendong Li2Yiran Xu3Tao Li4Tao Li5Joakim Ek6Xiaoli Zhang7Yafeng Wang8Yafeng Wang9Juan Song10Changlian Zhu11Changlian Zhu12Changlian Zhu13Xiaoyang Wang14Xiaoyang Wang15Xiaoyang Wang16Henan Key Laboratory of Child Brain Injury and Henan Pediatric Clinical Research Center, Institute of Neuroscience and Third Affiliated Hospital of Zhengzhou University, Zhengzhou, ChinaCenter for Brain Repair and Rehabilitation, Institute of Neuroscience and Physiology, University of Gothenburg, Gothenburg, SwedenHenan Key Laboratory of Child Brain Injury and Henan Pediatric Clinical Research Center, Institute of Neuroscience and Third Affiliated Hospital of Zhengzhou University, Zhengzhou, ChinaHenan Key Laboratory of Child Brain Injury and Henan Pediatric Clinical Research Center, Institute of Neuroscience and Third Affiliated Hospital of Zhengzhou University, Zhengzhou, ChinaCenter for Brain Repair and Rehabilitation, Institute of Neuroscience and Physiology, University of Gothenburg, Gothenburg, SwedenHenan Children’s Neurodevelopment Engineering Research Center, Children’s Hospital Affiliated to Zhengzhou University, Zhengzhou, ChinaCentre of Perinatal Medicine and Health, Institute of Neuroscience and Physiology, University of Gothenburg, Gothenburg, SwedenHenan Key Laboratory of Child Brain Injury and Henan Pediatric Clinical Research Center, Institute of Neuroscience and Third Affiliated Hospital of Zhengzhou University, Zhengzhou, ChinaCenter for Brain Repair and Rehabilitation, Institute of Neuroscience and Physiology, University of Gothenburg, Gothenburg, SwedenHenan Children’s Neurodevelopment Engineering Research Center, Children’s Hospital Affiliated to Zhengzhou University, Zhengzhou, ChinaHenan Key Laboratory of Child Brain Injury and Henan Pediatric Clinical Research Center, Institute of Neuroscience and Third Affiliated Hospital of Zhengzhou University, Zhengzhou, ChinaHenan Key Laboratory of Child Brain Injury and Henan Pediatric Clinical Research Center, Institute of Neuroscience and Third Affiliated Hospital of Zhengzhou University, Zhengzhou, ChinaCenter for Brain Repair and Rehabilitation, Institute of Neuroscience and Physiology, University of Gothenburg, Gothenburg, SwedenDepartment of Women’s and Children’s Health, Karolinska Institutet, Stockholm, SwedenHenan Key Laboratory of Child Brain Injury and Henan Pediatric Clinical Research Center, Institute of Neuroscience and Third Affiliated Hospital of Zhengzhou University, Zhengzhou, ChinaCentre of Perinatal Medicine and Health, Institute of Neuroscience and Physiology, University of Gothenburg, Gothenburg, SwedenCentre of Perinatal Medicine and Health, Institute of Clinical Science, University of Gothenburg, Gothenburg, SwedenIntroduction: Preterm brain injury often leads to lifelong disabilities affecting both cognitive and motor functions, and effective therapies are limited. Alpha1-antitrypsin (AAT), an endogenous inhibitor of serine proteinases with anti-inflammatory, anti-apoptotic, and cytoprotective properties, might be beneficial in treating preterm brain injury. The aim of this study was to investigate whether AAT has neuroprotective effects in a mouse preterm brain injury model.Methods: Preterm brain injury was induced on postnatal day 5, and mouse pups’ right common carotid arteries were cut between two ligations followed by hypoxia induction. Brain injury was evaluated through immunohistochemistry staining and magnetic resonance imaging. Fluoro-Jade B and immunohistochemistry staining were performed to investigate the neuronal cell death and blood-brain barrier (BBB) permeability. The motor function and anxiety-like behaviors were revealed by CatWalk gait analysis and the open field test.Results: After hypoxia-ischemia (HI) insult, brain injury was alleviated by AAT treatment, and this was accompanied by reduced BBB permeability, reduced neuronal cell death and caspase-3 activation, and inhibition of microglia activation. In addition, AAT administration significantly improved HI-induced motor function deficiencies in mice. The neuroprotective effect of AAT was more pronounced in male mice.Conclusion: AAT treatment is neuroprotective against preterm brain injury in neonatal mice, and the effect is more pronounced in males.https://www.frontiersin.org/articles/10.3389/fncel.2023.1137497/fullalpha1-antitrypsinneuroprotectionhypoxia-ischemianeonatal brain injuryimmature brainmotor dysfunction
spellingShingle Shan Zhang
Shan Zhang
Wendong Li
Yiran Xu
Tao Li
Tao Li
Joakim Ek
Xiaoli Zhang
Yafeng Wang
Yafeng Wang
Juan Song
Changlian Zhu
Changlian Zhu
Changlian Zhu
Xiaoyang Wang
Xiaoyang Wang
Xiaoyang Wang
Alpha1-antitrypsin protects the immature mouse brain following hypoxic-ischemic injury
Frontiers in Cellular Neuroscience
alpha1-antitrypsin
neuroprotection
hypoxia-ischemia
neonatal brain injury
immature brain
motor dysfunction
title Alpha1-antitrypsin protects the immature mouse brain following hypoxic-ischemic injury
title_full Alpha1-antitrypsin protects the immature mouse brain following hypoxic-ischemic injury
title_fullStr Alpha1-antitrypsin protects the immature mouse brain following hypoxic-ischemic injury
title_full_unstemmed Alpha1-antitrypsin protects the immature mouse brain following hypoxic-ischemic injury
title_short Alpha1-antitrypsin protects the immature mouse brain following hypoxic-ischemic injury
title_sort alpha1 antitrypsin protects the immature mouse brain following hypoxic ischemic injury
topic alpha1-antitrypsin
neuroprotection
hypoxia-ischemia
neonatal brain injury
immature brain
motor dysfunction
url https://www.frontiersin.org/articles/10.3389/fncel.2023.1137497/full
work_keys_str_mv AT shanzhang alpha1antitrypsinprotectstheimmaturemousebrainfollowinghypoxicischemicinjury
AT shanzhang alpha1antitrypsinprotectstheimmaturemousebrainfollowinghypoxicischemicinjury
AT wendongli alpha1antitrypsinprotectstheimmaturemousebrainfollowinghypoxicischemicinjury
AT yiranxu alpha1antitrypsinprotectstheimmaturemousebrainfollowinghypoxicischemicinjury
AT taoli alpha1antitrypsinprotectstheimmaturemousebrainfollowinghypoxicischemicinjury
AT taoli alpha1antitrypsinprotectstheimmaturemousebrainfollowinghypoxicischemicinjury
AT joakimek alpha1antitrypsinprotectstheimmaturemousebrainfollowinghypoxicischemicinjury
AT xiaolizhang alpha1antitrypsinprotectstheimmaturemousebrainfollowinghypoxicischemicinjury
AT yafengwang alpha1antitrypsinprotectstheimmaturemousebrainfollowinghypoxicischemicinjury
AT yafengwang alpha1antitrypsinprotectstheimmaturemousebrainfollowinghypoxicischemicinjury
AT juansong alpha1antitrypsinprotectstheimmaturemousebrainfollowinghypoxicischemicinjury
AT changlianzhu alpha1antitrypsinprotectstheimmaturemousebrainfollowinghypoxicischemicinjury
AT changlianzhu alpha1antitrypsinprotectstheimmaturemousebrainfollowinghypoxicischemicinjury
AT changlianzhu alpha1antitrypsinprotectstheimmaturemousebrainfollowinghypoxicischemicinjury
AT xiaoyangwang alpha1antitrypsinprotectstheimmaturemousebrainfollowinghypoxicischemicinjury
AT xiaoyangwang alpha1antitrypsinprotectstheimmaturemousebrainfollowinghypoxicischemicinjury
AT xiaoyangwang alpha1antitrypsinprotectstheimmaturemousebrainfollowinghypoxicischemicinjury